About: Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 21 February 2012

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2012 (ast) наукова стаття, опублікована в лютому 2012 (uk) scientific article published on 21 February 2012 (en) مقالة علمية نشرت في 21 فبراير 2012 (ar)
publication date	wds:Q37263116-B60D292A-51F3-46A0-B9F3-1E641A189B79
publication date	2012-02-21 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37263116-A0204CD2-DC23-41FF-AB69-9E7A886CD1A8
language of work or name	English
cites work	wds:Q37263116-03C10358-6BEB-47EE-B3A9-3DF53FB8E0CD wds:Q37263116-04BE6DAF-2163-4E5F-9800-D66D89D162D4 wds:Q37263116-1F74C278-EFB1-418C-8C19-C6D8B5BA0310 wds:Q37263116-223E0327-3EF3-49F5-99A4-AD3732E55952 wds:Q37263116-29B6C3E1-95D9-4D9C-BEC2-127C2185F570 wds:Q37263116-382430CE-FB06-4428-AC13-C2581790E2E3 wds:Q37263116-3A4ECB77-062E-44FC-9BE4-8A1229A9DC2D wds:Q37263116-3EE4C7CF-040C-42E5-A90E-04861E5B936E wds:Q37263116-4A5F44E5-3DE5-4994-9152-6D16D7ED062E wds:Q37263116-4BB67D36-2046-47FB-B0A8-6A20197CAAF6 wds:Q37263116-4D59DA0D-D10F-4305-9AFB-E7F69D2436E4 wds:Q37263116-5C1D2DA5-A547-4EA5-9EEB-47D3635508E5 wds:Q37263116-621E31EC-2481-412B-896D-80D17B679E5F wds:Q37263116-66685613-4A1B-4ADA-85C7-DF9B45D5C2A0 wds:Q37263116-70EA2D77-4D69-4E76-BC01-E0693BA98814 wds:Q37263116-89F31D96-FB63-4416-9646-AB673B0C7642 wds:Q37263116-8B94DEBF-D8D8-404B-A161-307C09863938 wds:Q37263116-93D6F740-8CC7-4D10-BE06-2453B5387513 wds:Q37263116-B31FE264-9CB1-4DBF-8B74-4EBD508DBB31 wds:Q37263116-D751183D-22FE-4975-9713-A11D4D0DCAEB wds:Q37263116-E54A80AC-61B7-4F97-9E52-EABCF6F9AAA6 wds:Q37263116-ED3EFD97-EC7D-4895-8384-D997D2C5CD5A
cites work	Marginal structural models and causal inference in epidemiology The control of confounding by intermediate variables Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods Structural accelerated failure time models for survival analysis in studies with time-varying treatments. The graft versus leukemia effect after bone marrow transplantation: a case study using structural nested failure time models A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection Prevention of HIV-1 infection with early antiretroviral therapy Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings Event history analysis and inference from observational epidemiology Effect of early versus deferred antiretroviral therapy for HIV on survival Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Should HIV therapy be started at a CD4 cell count above 350 cells/microl in asymptomatic HIV-1-infected patients? Should the CD4 threshold for starting ART be raised? Predicting the potential benefits of early initiation of ART: time to do a trial to find out Controlling the HIV epidemic, without a vaccine!
author name string	wds:Q37263116-141FC2BE-FF81-4985-B7D8-E993AA55515C wds:Q37263116-A8B43FB1-E9FE-4840-A81B-B8D3D440071F
author name string	Judith J Lok Victor DeGruttola
rdfs:label	Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (en) Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (nl) Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (ast)
skos:prefLabel	Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (en) Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (nl) Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (ast)
name	Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (en) Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (nl) Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (ast)
title	wds:Q37263116-A1DBF8D2-7B0D-487A-8291-94551B9A5CCA
title	Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients (en)
page(s)	wds:Q37263116-A39E263F-D413-4715-806B-65DB896BC17B
page(s)	745-754
instance of	wds:Q37263116-1E89715F-190C-41C8-850E-9D4E8B170F8A
instance of	scholarly article
PubMed ID	wds:Q37263116-DAAE0E28-DBCC-4FED-AC39-ABDD20DC0547
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22352840
PubMed ID	22352840
published in	wds:Q37263116-FD2CAF2B-EFB9-4422-9336-24592D3E5D80
published in	Biometrics
issue	wds:Q37263116-588AB6D1-0D83-4B82-BEB9-A5C6F93BA10A
volume	wds:Q37263116-7147D0C6-B99D-4C03-8E82-BC1947CB9E8B
issue	3
volume	68
DOI	wds:Q37263116-2984ADA6-7781-4CD6-A8CC-9548FFDC8EA6
DOI	http://dx.doi.org/10.1111/J.1541-0420.2011.01738.X
DOI	10.1111/J.1541-0420.2011.01738.X
maintained by WikiProject	wds:Q37263116-AD68C0DB-839D-466D-BB02-9235449A696F
maintained by WikiProject	WikiProject Mathematics
zbMATH Open document ID	wds:Q37263116-12842090-5B00-4C8B-9F2E-6920A4CC6D6F
zbMATH Open document ID	1270.62148

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software